Three Bridge Wealth Advisors’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$52.9K Buy
+1,155
New +$62.9K 0.01% 153

Other funds holding ELVN

Three Bridge Wealth Advisors's ELVN Position: Q3 2026 in Review

Three Bridge Wealth Advisors opened a new position in Enliven Therapeutics (ELVN) in Q3 2026: 1,155 shares worth $52.9K. The stake represents 0.01% of the portfolio and ranks #153 among its holdings.

216 funds tracked by Wall St. Rank hold ELVN as of Q3 2026.

  • Three Bridge Wealth Advisors held 1,155 shares of Enliven Therapeutics worth $52.9K as of Q3 2026.
  • Enliven Therapeutics was a new Three Bridge Wealth Advisors position in Q3 2026.
  • Enliven Therapeutics made up 0.01% of Three Bridge Wealth Advisors's portfolio in Q3 2026, its #153 holding.
  • 216 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q3 2026.

Based on Three Bridge Wealth Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.